Caspase I-related protease inhibition retards the execution of okadaic acid- and camptothecin-induced apoptosis and PAI-2 cleavage, but not commitment to cell death in HL-60 cells

British Journal of Cancer

Volumn 79, Issue 11-12, 1999, Pages 1685-1691

  Jensen, P H ^a   Fladmark, K E ^b   Gjertsen, B T ^b   Vintermyr, O K ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Apoptosis; Camptothecin; Caspase 1; HL 60 cells; Okadaic acid; PAI 2

Indexed keywords

CAMPTOTHECIN; DNA FRAGMENT; INTERLEUKIN 1BETA CONVERTING ENZYME; OKADAIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEINASE; PROTEINASE INHIBITOR; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL STRAIN HL 60; CELL STRUCTURE; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MYELOID LEUKEMIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEINASE INHIBITION;

EID: 0033067526     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690269     Document Type: Article

References (34)

1. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW and Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87: 171
2. Bialojan C and Takai A (1988) Inhibitory effect of a marine sponge toxin, okadaic acid, on protein phosphatases. Biochem J 256: 283-290
3. Bøoe R, Gjertsen BT, Vintermyr OK, Houge G, Lanotte M and Døskeland SO (1991) The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res 195: 237-246
4. Bøoe R, Gjertsen BT, Døskeland SO and Vintermyr OK (1995) 8-CI-cAMP triggers apoptosis in human mammary carcinoma cells (MCF-7) independently of the cAMP kinase. Br J Cancer 72: 1151-1159
5. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326: 1-16
6. Cohen P, Holmes CFB and Tsukitani Y (1990) Okadaic acid: a new probe for the study of cellular regulation. TIBS 15: 98-102
7. Clarke PG (1990) Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 181: 195-213
8. Del Bino G, Bruno S, Yi PN and Darzynkiewicz Z (1992) Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation. Cell Prolif 25: 537-548
9. Dickinson JL, Bates EJ, Ferrante A and Antalis TM (1995) Plasminogen activator inhibitor type 2 inhibits tumour necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem 270: 27894-27904
10. Dickinson JL, Norris BJ, Jensen PH and Antalis TM (1998) The CD-interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNFalfa induced apoptosis. Cell Death Diff 5: 163-171
11. Gjertsen BT and Døskeland SO (1995) Protein phosphorylation in apoptosis. Biochim Biophys Acta 1269: 187-199
12. Gjertsen BT, Cressey LI, Ruchaud S, Houge G, Lanotte M and Døskeland SO (1994) Multiple apoptotic death types triggered through activation of separate pathways by cAMP and inhibitors of protein phosphatases in one (IPC leukemia) cell line. J Cell Sci 107: 3363-3377
13. Golstein P (1997) Controlling cell death. Science 275: 1081-1082
14. Greenlund LJS, Korsmeyer SJ and Johnson EM Jr (1995) Role of bcl-2 in the survival and function of developing and mature sympathetic neurons. Neuron 15: 649-661
15. Jacobson MI, Burne JF and Raff MC (1994) Programmed cell death and bcl-2 protection in the absence of a nucleus. EMBO J 13: 1899-1910
16. Jensen PH (1997) Structure and function of plasminogen activator inhibitor-2: an intracellular serine proteinase inhibitor modulating apoptosis. Int J Oncol 11: 557-570
17. Jensen PH, Christensen EI, Ebbesen P, Gliemann J and Andreasen PA (1990) Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. Cell Reg 1: 1043-1056
18. Jensen PH, Cressey LI, Gjertsen BT, Madsen P, Mellgren G, Hokland P, Gliemann J, Døskeland SO, Lanotte M and Vintermyr OK (1994) Cleaved intracellular plasminogen activator inhibitor-2 in human myeloleukemia cells is a marker of apoptosis. Br J Cancer 70: 834-840
19. Jensen PH, Jensen TG, Laug WE, Hager H, Gliemann J and Pepinsky B (1996) The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain. J Biol Chem 271: 26892-26899
20. Kerr JFR, Wyllie AH and Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257
21. Kiguchi K, Glesne D, Chubb CH, Fujiki H and Hubermann E (1994) Differential induction of apoptosis in human breast tumour cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A. Cell Growth Diff 5: 995-1004
22. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MSS and Flavell RA (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Nature 267: 1998-2002
23. Kumar S and Baglioni C (1991) Protection from tumour necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J Biol Chem 266: 20960-20964
24. McCarthy NJ, Whyte MKB, Gilbert CS and Evan GI (1997) Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the bcl-2 homologue bak. J Cell Biol 136: 215-227
25. Mellgren G, Bruland T, Døskeland AP, Flatmark T, Vintermyr OK and Døskeland SO (1997) Synergistic antiproliferative actions of cyclic adenosine 3′,5′-monophosphate, interleukin-1β and activators of Ca++/calmodulin-dependent protein kinase in primary hepatocytes. Endocrinology 138: 4373-4383
26. Nicholson DW and Thornberry NA (1997) Caspases: Killer proteases. TIBS 22 299-306
27. Quan LT, Caputo A, Bleackley RC, Pickup DJ and Salvesen GS (1995) Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier. J Biol Chem 270: 10377-10379
28. Ray CA, Black RA, Kronheim SR, Greenstreen TA, Sleath PR, Salvesen GS and Pickup DJ (1992) Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1-beta converting enzyme. Cell 69: 597-604
29. Rothenberg ML (1997) Topoisomerase I inhibitors: review and update. Ann Oncol 8: 837-855
30. Schumann RR, Belka C, Reuter D, Lamping N, Kirschning CJ, Weber JR and Pfeil D (1998) Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood 15: 577-584
31. Shimizu T and Pommier Y (1997) Campotothecin-induced apoptosis in p53-null human leukemia HL-60 cells and their isolated nuclei: effect of the protease inhibitors Z-VAD-fmk dichloroisocoumarin suggest an involvement of both caspases and serine proteases. Leukemia 11: 1238-1244
32. Toivola DM, Goldman RD, Garrod DR and Eriksson JE (1997) Protein phosphatases maintain the organization and structural interactions of hepatic keratin intermediate filaments. J Cell Sci 110: 23-33
33. Wyllie AH, Kerr JF and Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-305
34. Zhivotovki B, Gahm A, Ankarerona M, Nicotera P and Orrenius S (1995) Multiple proteases are involved in thymocyte apoptosis. Exp Cell Res 221: 404-412